Skip to content

Observational Study on the Patients With Pain Medications

Observational Study on the Patients With Pain Medications

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00771212
Enrollment
2636
Registered
2008-10-13
Start date
2007-10-31
Completion date
2008-05-31
Last updated
2014-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

Pain, Observational, Taiwan

Brief summary

The purpose of this study is to describe the use of pain treatments in Taiwan, the demographics, clinical characteristics of patients requiring pain treatments, current treatments, outcomes of treatments and the reasons for changing pain medication during treatment.

Detailed description

This is a Phase IV, multi-center, observational study to describe the use of pain treatments, the demographics, clinical characteristics of patients requiring pain treatments, current treatments, outcomes of treatments and the reasons for changing pain medication during treatment. The study is conducted in an effort to understand the status of pain control in Taiwan. Currently in Taiwan, there is no approved documentation showing the most effective standard medication for treatment of patients in pain. Observational study with no study medication administered.

Interventions

OTHERObservational pain control study

Observational pain control study

Sponsors

Johnson & Johnson Taiwan Ltd
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Outpatients only * Patients must have pain, previously treated with and without medication and have a VAS (Visual analogue scale) score recorded at the enrolment time * Patient must have a VAS score \>4

Exclusion criteria

* Patients who are receiving any investigational drug during the study * Patients with known or suspected psychotic disease or mental retardation.

Design outcomes

Primary

MeasureTime frame
To describe effective use of pain medications, describe demographics, clinical characteristics of patients requiring pain treatments, current treatments, outcomes of treatments and the reasons for changing pain medication during treatment in Taiwan60 days

Secondary

MeasureTime frame
Pain Relief Rating Scale60 days
Sleeping quality Assessment60 days
Global Assessments (Patient/Investigator)60 days

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026